201 related articles for article (PubMed ID: 15366674)
1. [Impact of Helicobacter pylori infection on the risk of gastro-duodenal ulcer in patients treated with nonsteroidal antiinflammatory drugs].
Thiéfin G; Jolly D
Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C45-57. PubMed ID: 15366674
[TBL] [Abstract][Full Text] [Related]
2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
3. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Hunt RH; Bazzoli F
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
[TBL] [Abstract][Full Text] [Related]
4. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
6. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
7. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J; Saito Y; Honda A; Matsuzaki Y
World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.
McCarthy DM
Scand J Gastroenterol Suppl; 1991; 187():91-7. PubMed ID: 1775931
[TBL] [Abstract][Full Text] [Related]
11. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
12. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
Thiéfin G
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.
Chan FK
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):1-3. PubMed ID: 11782567
[TBL] [Abstract][Full Text] [Related]
14. [Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].
Sokić-Milutinović A; Krstić M; Popović D; Mijalković N; Djuranović S; Culafić Dj
Acta Chir Iugosl; 2007; 54(1):51-62. PubMed ID: 17633863
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
Papatheodoridis GV; Archimandritis AJ
World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
Chan FK
Gastroenterol Clin North Am; 2001 Dec; 30(4):937-52. PubMed ID: 11764536
[TBL] [Abstract][Full Text] [Related]
17. Review article: the effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury.
Laine L
Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():34-9. PubMed ID: 11849126
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]